Lung transplantation at Duke University Medical Center.

Journal Article

Lung transplantation is a viable therapy for patients with a variety of end-stage lung diseases. Our active program now includes over 200 lung transplant operations with acceptable one- and 3-year survival rates of 78% and 61%. A major focus of clinical research at this institution is to design strategies to prevent the development of chronic allograft dysfunction. Our preliminary work in this regard has been encouraging. In addition, a major research focus has been to design protocols to prevent the development of posttransplant infections. Our work with aerosolized ABLC represents a major advance at our center, and additional randomized prospective studies are ongoing to define the optimal antifungal prophylaxis after transplantation. Ongoing clinical and basic research at Duke and elsewhere should continue to advance the field of clinical transplantation and ultimately lead to more acceptable long-term outcomes for lung allograft recipients.

Full Text

Duke Authors

Cited Authors

  • Lau, CL; Palmer, SM; D'Amico, TA; Tapson, VF; Davis, RD

Published Date

  • January 1, 1998

Published In

Start / End Page

  • 327 - 340

PubMed ID

  • 10503111

International Standard Serial Number (ISSN)

  • 0890-9016

Language

  • eng

Conference Location

  • United States